NO951570L - Anti-inflammatorisk faktor, fremgangsmåte for isolering derav og anvendelse - Google Patents

Anti-inflammatorisk faktor, fremgangsmåte for isolering derav og anvendelse

Info

Publication number
NO951570L
NO951570L NO951570A NO951570A NO951570L NO 951570 L NO951570 L NO 951570L NO 951570 A NO951570 A NO 951570A NO 951570 A NO951570 A NO 951570A NO 951570 L NO951570 L NO 951570L
Authority
NO
Norway
Prior art keywords
isolation
inflammatory factor
factor
cells
inflammatory
Prior art date
Application number
NO951570A
Other languages
English (en)
Norwegian (no)
Other versions
NO951570D0 (no
Inventor
Lee R Beck
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Publication of NO951570D0 publication Critical patent/NO951570D0/no
Publication of NO951570L publication Critical patent/NO951570L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO951570A 1992-10-27 1995-04-25 Anti-inflammatorisk faktor, fremgangsmåte for isolering derav og anvendelse NO951570L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/966,741 US5352462A (en) 1982-06-03 1992-10-27 Anti-inflammatory factor, method of isolation, and use
PCT/US1993/008935 WO1994009799A1 (en) 1992-10-27 1993-09-22 Anti-inflammatory factor, method of isolation, and use

Publications (2)

Publication Number Publication Date
NO951570D0 NO951570D0 (no) 1995-04-25
NO951570L true NO951570L (no) 1995-06-26

Family

ID=25511810

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951570A NO951570L (no) 1992-10-27 1995-04-25 Anti-inflammatorisk faktor, fremgangsmåte for isolering derav og anvendelse

Country Status (15)

Country Link
US (1) US5352462A (fi)
EP (1) EP0746329B1 (fi)
JP (3) JPH08502515A (fi)
KR (1) KR100310899B1 (fi)
AT (1) ATE217797T1 (fi)
AU (1) AU679006B2 (fi)
CA (1) CA2146442C (fi)
DE (1) DE69331957T2 (fi)
FI (1) FI115383B (fi)
IL (2) IL107392A (fi)
MX (1) MX9306686A (fi)
NO (1) NO951570L (fi)
NZ (1) NZ256576A (fi)
TW (1) TW389695B (fi)
WO (1) WO1994009799A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650175A (en) * 1982-06-03 1997-07-22 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5980953A (en) * 1994-10-03 1999-11-09 Stolle Milk Biologics, Inc. Anti-inflammatory factor, method of isolation, and use
DE19548221C1 (de) * 1995-12-22 1997-05-15 Biotest Pharma Gmbh Orale Anwendung von Immunglobulin-Präparationen zur Behandlung und Prophylaxe chronischer Schmerzzustände
CN1178671C (zh) * 1996-03-26 2004-12-08 Dcv公司 蛋抗炎成分、分离方法和用途
US5772999A (en) * 1996-07-30 1998-06-30 Dcv Biologics, L.P. Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
JP4451933B2 (ja) * 1996-12-27 2010-04-14 住友化学株式会社 遺伝子操作による植物へのｐｐｏ阻害性除草剤耐性付与法
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
WO2001013928A1 (fr) * 1999-08-24 2001-03-01 Ortho Corporation Co., Ltd. Procedes de pasteurisation d'une substance immune contenant un facteur anti-inflammatoire et son utilisation
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
US20080026983A1 (en) * 2006-07-28 2008-01-31 Gardiner Paul T Compositions and methods for alleviating joint pain and improving joint flexibility

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
GB1211876A (en) * 1967-11-23 1970-11-11 Twyford Lab Ltd Improvements in and relating to prophylactic and therapeutic preparations
CH590064A5 (fi) * 1973-11-28 1977-07-29 Biokema Sa
US4324782A (en) * 1974-01-28 1982-04-13 Beck Lee R Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
DE3172807D1 (en) * 1981-04-28 1985-12-12 Stolle Res & Dev Method of obtaining an anti-inflammatory bovine milk
JPS58136137A (ja) * 1982-02-08 1983-08-13 Hitachi Ltd 電界効果トランジスタを用いたインバータ回路
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5242691A (en) * 1982-06-03 1993-09-07 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4879110A (en) * 1983-10-27 1989-11-07 Stolle Research And Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
US4897265A (en) * 1983-10-27 1990-01-30 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
JPS6049377A (ja) * 1983-08-30 1985-03-18 Canon Inc 画像処理装置
JPS6135616A (ja) * 1984-07-27 1986-02-20 Tdk Corp 電界効果トランジスタ駆動回路
JPS63139421A (ja) * 1986-12-01 1988-06-11 Fuji Electric Co Ltd Ｍｏｓｆｅｔのゲ−ト駆動回路
EP0300102B1 (en) * 1987-07-21 1993-03-24 The Stolle Research And Development Corporation Improved method of obtaining immune regulatory factors by mammal immunization
JPH022704A (ja) * 1988-06-15 1990-01-08 Matsushita Electric Works Ltd 半導体スイッチング素子の駆動回路
JPH0250616A (ja) * 1988-08-12 1990-02-20 Matsushita Electric Works Ltd トランジスタ駆動回路
US4897580A (en) * 1989-06-20 1990-01-30 Motorola Inc. Amplifier drive circuit for inductive loads

Also Published As

Publication number Publication date
JP2008074861A (ja) 2008-04-03
CA2146442C (en) 2005-01-25
JP2006036785A (ja) 2006-02-09
IL107392A0 (en) 1994-01-25
AU5134093A (en) 1994-05-24
NO951570D0 (no) 1995-04-25
DE69331957T2 (de) 2003-01-16
IL121464A0 (en) 1998-02-08
DE69331957D1 (de) 2002-06-27
KR950703983A (ko) 1995-11-17
CA2146442A1 (en) 1994-05-11
WO1994009799A1 (en) 1994-05-11
EP0746329B1 (en) 2002-05-22
FI951980A0 (fi) 1995-04-26
MX9306686A (es) 1994-06-30
ATE217797T1 (de) 2002-06-15
IL107392A (en) 1998-09-24
FI115383B (fi) 2005-04-29
NZ256576A (en) 1997-05-26
TW389695B (en) 2000-05-11
AU679006B2 (en) 1997-06-19
FI951980A (fi) 1995-05-31
KR100310899B1 (ko) 2001-12-17
EP0746329A4 (en) 1996-06-18
EP0746329A1 (en) 1996-12-11
US5352462A (en) 1994-10-04
JPH08502515A (ja) 1996-03-19

Similar Documents

Publication Publication Date Title
NO951570L (no) Anti-inflammatorisk faktor, fremgangsmåte for isolering derav og anvendelse
ITTO930309A0 (it) Sistema per il riconoscimento di parole isolate indipendenti dal parlatore mediante reti murali.
DK0787007T3 (da) Antiinflammatorisk faktor, isoleringsfremgangsmåde og anvendelse
IT1266734B1 (it) Gruppo per la molatura di lastre di vetro.
FI921059A (fi) Menetelmä hyötyproteiinien erittämiseksi hiivoista
EP0326550A4 (en) PROCESS FOR THE USE OF AN ISOLATED EXOCELLULAR POLYSACCHARIDE FROM ZOOGLOEA RAMIGERA.
MY117908A (en) Anti-inflammatory factor, method of isolation, and use
PT731709E (pt) Inibidores de neutrofilos provenientes nematodos
DK600187A (da) Fremgangsmaade til at fremme udskillelse af amylolytiske enzymer fra bakterier samt ved fremgangsmaaden opnaaede enzymer
IT1172204B (it) Sistema per la utilizzazione di gas di altoforno
IT8820916A0 (it) Procedimento ed impianto per la coltura di microorganismi.
IT8121773A0 (it) Proteine da foglie di piante. procedimento per l'isolamento di
ITPA930012A0 (it) Metodo per l'eliminazione del mal di testa.
IT8021135V0 (it) Dispositivo per l'applicazione di lastre di vetro multiple su serramenti in genere.
IT8524088V0 (it) Recipiente per la coltura di microorganismi.
IT1210378B (it) Sistema strutturale modulare particolarmente utilizzabile per la formazione di pareti divisorie componibili e variamente attrezzabili.
IT8734017V0 (it) Sistema strutturale modulare particolarmente utilizzabile per la formazione di pareti divisorie componibili e variamente attrezzabili.
ITFI920086A0 (it) " metodo per la separazione del quarzo dai feldspadi ".
IT8020514V0 (it) Stelo per il sostegno di elementi in fogli intercambiabili.
IT8063309V0 (it) Sistema di unione ad incastro, particolarmente adatto, per componenti metallici di scaffalature modulari.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application